Ambu, DK0060946788

Ambu stock falls 1.52 percent and buyback program ends

Published on 09/25/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock stood at DKK 67.90 on September 25, 2026. Q3 fiscal 2026 revenue reached DKK 1.64 billion and adjusted EBITDA rose to DKK 321 million.

Fotorealistische Medizintechnik-Fertigung von Einweg-Endoskopen im Reinraum
Ambu A/S (DK0060946788) zeigt fotorealistisch moderne Medizintechnik-Fertigung von Einweg-Endoskopen in steriler Reinraumumgebung, Illustration mit AI erstellt.

Ambu stock (ISIN DK0060946788) fell 1.52 percent to DKK 67.90 on Nasdaq Copenhagen on September 25, 2026 at 4:19 p.m. CEST. The company had completed a DKK 300 million share buyback program on September 21, 2026, according to MarketScreener.

Buyback reaches its final date

The program repurchased 4.49 million shares at an average price of DKK 66.78, with treasury stock reaching 8.64 million shares, or 3.2 percent of share capital, on September 21, 2026.

The repurchase therefore covered a material portion of the issued equity, while the stock still traded DKK 1.10 above the program's reported average purchase price at the September 25 snapshot.

Quarterly growth remains measurable

Ambu reported Q3 fiscal 2026 revenue of DKK 1.64 billion for the quarter ended June 30, 2026, up 8.8 percent from DKK 1.51 billion a year earlier, according to Zonebourse.

Adjusted EBITDA rose 22.1 percent to DKK 321 million from DKK 263 million, lifting the adjusted EBITDA margin to 19.6 percent from 17.5 percent in the comparable quarter.

Operating profit increased 30.0 percent to DKK 221 million from DKK 170 million, while operating margin reached 13.5 percent versus 11.3 percent previously. Operating cash flow rose 39.7 percent to DKK 331 million from DKK 237 million.

Analyst target stays above the quote

On September 15, 2026, UBS downgraded Ambu to neutral from buy and cut its price target to DKK 72 from DKK 96, as reported by MarketScreener.

The DKK 72 target lies 6.0 percent above the DKK 67.90 intraday price. The wider average analyst target stood at DKK 81.77, with a mean consensus of Hold from eight analysts, according to MarketScreener.

Ambu stock remains below its yearly high

At DKK 67.90, Ambu stock stood within its DKK 56.25 to DKK 111.80 52-week range on September 25, 2026. The session range was DKK 67.75 to DKK 69.45, with volume of 221,567 shares.

Market capitalization was DKK 18,047,533,596 on the same snapshot. The combination of double-digit EBITDA growth, a completed repurchase program and a lower UBS target leaves operating execution and valuation as the central stock variables.

Ambu stock snapshot

  • Company: Ambu A/S
  • ISIN: DK0060946788
  • Ticker: AMBU B
  • Trading venue: Nasdaq Copenhagen
  • Price (as of September 25, 2026, 4:19 p.m. CEST): DKK 67.90 (intraday)
  • Market capitalization: DKK 18,047,533,596 (as of September 25, 2026)
  • 52-week range: DKK 56.25-111.80 (as of September 25, 2026)
  • Sector / Industry: Medical Equipment, Supplies and Distribution

More news and analyses on Ambu stock

Disclaimer...

en | DK0060946788 | AMBU | boerse | 70184253 | bgmi